Employing SIRT3 KO in a murine model of metabolic syndrome revealed that greater than 90% of SIRT3 KO mice developed HCC, providing an association with SIRT3 activity, metabolic syndrome, mitochondrial protein acetylation, and cancer progression [182]. The gene discussed is SIRT3; the disease is cancer.